Cite
HARVARD Citation
Park, S. et al. (2019). PRPF4 is a novel therapeutic target for the treatment of breast cancer by influencing growth, migration, invasion, and apoptosis of breast cancer cells via p38 MAPK signaling pathway. Molecular and cellular probes. p. . [Online].